PRIMARY STUDY

Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial

Key Findings:  Resulting data revealed that CBD and PEA reduce permeability in the human colon with potential relevance to patients with colitis.